Bluejay Diagnostics Files 2024 Annual Report Amendment
Ticker: BJDX · Form: 10-K/A · Filed: 2025-04-29T00:00:00.000Z
Sentiment: neutral
Topics: amendment, annual-report, disclosures
TL;DR
Bluejay Diagnostics filed its amended 2024 10-K on 4/29/25. Check for updates.
AI Summary
Bluejay Diagnostics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, dated April 29, 2025, provides updated information for the company, which is incorporated in Delaware and headquartered in Acton, MA. The company operates in the surgical and medical instruments and apparatus industry.
Why It Matters
This amendment provides updated financial and operational information for investors and stakeholders, crucial for understanding the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to an annual report, typically containing updated disclosures rather than significant new risks.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the reporting period for the annual report.)
- 001-41031 — SEC File Number (Unique identifier for the company's filings with the SEC.)
Key Players & Entities
- Bluejay Diagnostics, Inc. (company) — Filer of the 10-K/A
- 2024 (date) — Fiscal year end for the report
- April 29, 2025 (date) — Filing date of the amendment
- Acton, MA (location) — Principal executive offices location
- 001-41031 (company) — SEC file number
FAQ
What specific information was updated in this Amendment No. 1 to the 10-K?
The filing is an amendment to the 10-K for the fiscal year ended December 31, 2024, indicating that updates or corrections were made to the original filing.
When was the original 10-K filed, and what is the purpose of this amendment?
The amendment was filed on April 29, 2025. Amendments are filed to correct or update information previously submitted in an SEC filing.
What is Bluejay Diagnostics, Inc.'s primary business sector?
Bluejay Diagnostics, Inc. is in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, with SIC code 3841.
Where are Bluejay Diagnostics, Inc.'s principal executive offices located?
The company's principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
What is the SEC file number for Bluejay Diagnostics, Inc.?
The SEC file number for Bluejay Diagnostics, Inc. is 001-41031.
From the Filing
0001213900-25-036783.txt : 20250429 0001213900-25-036783.hdr.sgml : 20250429 20250429160008 ACCESSION NUMBER: 0001213900-25-036783 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250429 DATE AS OF CHANGE: 20250429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bluejay Diagnostics, Inc. CENTRAL INDEX KEY: 0001704287 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 473552922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41031 FILM NUMBER: 25886926 BUSINESS ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: (978) 631-0152 MAIL ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 10-K/A 1 ea0239880-10ka1_bluejay.htm AMENDMENT NO. 1 TO FORM 10-K     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 10-K/A (Amendment No. 1)   (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the Fiscal Year Ended December 31 , 2024   Or   ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Commission file number: 001-41031   Bluejay Diagnostics, Inc.  (Exact Name of Registrant as Specified in Its Charter)   Delaware   47-3552922 (State or Other Jurisdiction of Incorporation or Organization)   (I.R.S. Employer Identification No.)   360 Massachusetts Avenue , Suite 203 , Acton , MA   01720 (Address of Principal Executive Offices)   (Zip Code)   (844) 327-7078 (Registrant’s Telephone Number, Including Area Code)   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.001 per share   BJDX   The Nasdaq Stock Market LLC   Securities registered pursuant to section 12(g) of the Act: None   Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ☐   No   ☒   Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐   No   ☒   Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No  ☐   Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒  No  ☐   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.   Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒   If an emerging growth company, indicate by che